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adult dog model, two 5-mm longitudinal tears were created in the
avascular portion of the medial meniscus. Each tear was treated
with one BioDuct® implant placed at the tear site (n=10), fol-
lowed by suture repair. After 16 weeks, both knees were assessed
for gross pathology, articular cartilage damage (India ink stain-
ing), and repair tissue appearance. Limbs were processed for 3T
MRI and histologic examination (n=4) or biomechanical evaluation
(n=6). MRI evaluation utilized a water-sensitive, moderate echo
time fast spin echo protocol previously applied clinically, with a
resolution of 175 μm by 187.5 μm by 1.2 mm. Meniscal healing
was made based on the presence or absence of ﬂuid inhibition
into the repair site as well as any discernible fragmentation.
Results: In vitro, the PLLA and 85/15 materials did not lose
mass throughout the study. The 50/50 and 10/90 samples began
to lose mass after 3 and 1 week, respectively and were almost
completely degraded by 7 weeks. The inherent viscosity of the
materials decreased more rapidly with increasing PGA content.
The 3-point bend and crush strength properties of the implants
were found to decrease with time, with the exception of PLLA.
Figure 1. Biomechanical strength of repaired tear.
In vivo, all of the BioDuct® implant groups provided function-
ally healed avascular meniscal tissue in the dogs, independent of
bioabsorbable polymer tested. Tear strengths of the repaired avas-
cular tissue acquired 35-58% of contralateral, unoperated tissue
(Fig. 1). Histological analysis showed evidence of tissue ingrowth
and guided tissue engineering through the lumen of the conduit
(Fig. 2). MRI analyses conﬁrmed healing in 6 out of 8 anterior
repairs and 7 out of 8 posterior repairs where the conduit was
used (Fig. 3). Mild to moderate synovitis and chondral defects not
necessarily associated with the use of the implant were observed
with MRI; however, these defects were not apparent at gross
necropsy via India ink staining.
Figure 2. Denovo tissue in BioDuct conduit
lumen.
Figure 3. Sagittal fast spin echo
MR demonstrates lack of ﬂuid
inhibition, suggesting healing.
Conclusions: This study demonstrated the success of BioDuct®
repair in enabling healing of avascular tear in a dog meniscus,
independent of the PLA/PGA materials tested.
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Purpose: Meniscus repairs with sutures have become more com-
mon as the importance of preserving the meniscus has been
established. Studies have shown a high rate of repeat surgery,
but it is unclear what factors contribute to failure. The purpose
of this study was to determine what factors lead to failure of su-
ture meniscus repair. Failure was operationally deﬁned as repeat
surgery on the meniscus within 2 years of the repair.
Methods: Two hundred eighty-three (283) meniscus suture re-
pairs were performed by a single surgeon. The average patient
age was 31 years (range, 18 to 71). There were 177 males
and 106 females. All repairs were completed with an inside-out
suture technique. One hundred thirty-seven (137) had an ACL re-
construction and meniscus repair (93 concurrent reconstructions
and 44 two-staged ACL reconstructions). One hundred eighty-one
(181) medial menisci and 102 lateral menisci were repaired. Of the
medial repairs, 80% were in the posterior third of the meniscus,
11% in the middle third, 1% in the anterior third, and 8% extended
to all areas of the meniscus. Of the lateral meniscus repairs, 49%
were in the posterior third, 26% in the middle third, 22% in the
anterior third, and 3% extended to all areas.
Results: Twenty-eight (28) patients (10%) had required repeat
surgery on the repaired meniscus within the ﬁrst 2 years and were
considered failures. The average time to repeat meniscus surgery
was 12 months (range, 2.5 to 24 months).There were no differ-
ences based on age, gender or location. Thirteen percent (13%)
of medial repairs and 4% of lateral repairs failed (p=0.012). Me-
dial meniscus repairs failed signiﬁcantly earlier (5.6 months) than
lateral meniscus repairs (12.9 months) (p=0.001). For patients
who had ACL reconstruction and meniscus repair, factors associ-
ated with failure included age (failed age=22; non-failure age=29;
p=0.013), and concurrent ACL reconstruction (two-staged repair
failures=2%; concurrent repair failures=11%; p=0.04).
Conclusions: Failure of suture repair of the meniscus within the
ﬁrst two years following index repair is more likely to occur in
medial meniscus repairs and in young patients who had a repair
and concurrent ACL reconstruction.
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Purpose: Tendons have a limited capacity for self-repair due to low
cell density and little mitotic activity. Pro-inﬂammatory cytokines
such as interleukin-1β (IL-1β) have been identiﬁed as the main
initiators of tendinopathies, stimulating inﬂammation, apoptosis
and extracellular matrix (ECM) degradation. The aim of this study
was to evaluate the potential of Tendoactive®, a nutraceutical
formulation that contains mucopolysaccharides, hydrolyzed type I
collagen and vitamin C, in an in vitro model of tendon inﬂammation.
Methods: In monolayer cultures, primary human tenocytes were
either treated with Tendoactive®, non-stimulated or stimulated with
